Cantor Fitzgerald Maintains Overweight on AvePoint, Raises Price Target to $19
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Cantor Fitzgerald analyst Thomas Blakey maintains AvePoint (NASDAQ:AVPT) with a Overweight and raises the price target from $15 to $19.
Cantor Fitzgerald analyst Thomas Blakey maintains AvePoint (NASDAQ:AVPT) with a Overweight and raises the price target from $15 to $19.